O
Ossium Health
Building the world's first bone marrow bank to treat blood cancers
About Ossium Health
Ossium Health is a pioneering biotechnology company focused on developing advanced cell therapies to improve human health, vitality, and longevity. Operating in the healthcare and life sciences sector, Ossium Health collaborates with healthcare providers, life science companies, and organ procurement organizations to create and deploy innovative treatments. The company specializes in utilizing stem cells sourced from deceased donors to address diseases of the blood and immune systems, organ transplant rejection, and orthopedic conditions. Ossium Health's business model revolves around research and development, clinical trials, and partnerships to bring their therapies to market. Revenue is generated through collaborations, licensing agreements, and sales of their proprietary cell therapy products.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jul 2023 | $52M | $315M | Vivo Capital · First Round Capital · CPMG · Alumni Ventures | ↗ |
| GRANTOther financing | Apr 2023 | $3.5M | — | California Institute for Regenerative Medicine | ↗ |
Growth signals
Latest recorded traffic for Ossium Health is 6.2K monthly website visits, up 59% over the last three months. Ossium Health's team grew 12.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Ossium Health in the San Francisco ecosystem
The Ossium Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
First Round Capital
National Institutes of Health
California Institute for Regenerative Medicine
Series A4 investors entered at this stage
Vivo Capital
General Catalyst
Manta Ray Ventures
XYZ Capital
Series B and later3 investors entered at this stage
- CPCPMG
Alumni Ventures
Asahi Kasei Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ossium Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ossium Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







